Lexington, MA, United States of America

Zhong Ma

This inventor holds 20 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Complement Modulation. Top assignees: Ra Pharmaceuticals, Inc., Merck Sharp + Dohme Corp.. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhong Ma. Retrieved from https://idiyas.com/inventor/zhong-ma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 75.0

 

 

Average Co-Inventor Count = 14.3

ph-index = 6

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Complement Activity
Cyclic Polypeptides
PCSK9 Inhibition
Ras Binding Peptides
Peptide Inhibitors
Peptidomimetics
Modulators
Biological Activity
20 patents (USPTO):Explore Patents

Title: Innovative Contributions of Zhong Ma: A Modern Inventor in Complement Modulation

Introduction: Zhong Ma, based in Lexington, MA, is a prominent inventor known for his significant contributions in the field of complement activity modulation. With an impressive portfolio of 20 patents, he has made strides in developing therapies that target the complement system, which plays a crucial role in the immune response.

Latest Patents: Among his latest inventions are two notable patents related to modulators of complement activity. The first patent introduces polypeptide modulators of complement activity, including cyclic polypeptide modulators. The second patent focuses on modulators of complement activity and outlines methods for utilizing such modulators as therapeutics. These innovations highlight his commitment to advancing therapeutic options in immunology.

Career Highlights: Throughout his career, Zhong Ma has collaborated with leading pharmaceutical companies such as Ra Pharmaceuticals, Inc. and Merck Sharp & Dohme Corporation. His work at these organizations has propelled forward research and development in the medical field, particularly in the area of complement system modulation.

Collaborations: Zhong Ma has worked alongside esteemed colleagues like Alonso Ricardo and Kristopher Josephson. These collaborations have fostered a robust exchange of ideas and shared expertise, contributing to the successful development of groundbreaking therapies.

Conclusion: Zhong Ma's inventive spirit and dedication to scientific advancement are evident in his multiple patents and collaborations. His work not only reflects his innovative mindset but also contributes significantly to the landscape of modern therapeutics aimed at modulating the complement system. As the field continues to evolve, the impact of his contributions will undoubtedly shape future research and therapies in immunology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…